Literature DB >> 6754061

A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.

A Lipton, H A Harvey, R J Santen, A Boucher, D White, A Bernath, R Dixon, G Richards, A Shafik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754061     DOI: 10.1002/1097-0142(19821201)50:11<2265::aid-cncr2820501106>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

Review 1.  Solving the puzzle of hormone-dependent breast cancer.

Authors:  R J Santen
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 2.  The sequential use of endocrine treatment for advanced breast cancer: where are we?

Authors:  C Barrios; J F Forbes; W Jonat; P Conte; W Gradishar; A Buzdar; K Gelmon; M Gnant; J Bonneterre; M Toi; C Hudis; J F R Robertson
Journal:  Ann Oncol       Date:  2012-02-08       Impact factor: 32.976

Review 3.  Aromatase inhibitors: past, present and future in breast cancer therapy.

Authors:  Udayan Dutta; Kartikeya Pant
Journal:  Med Oncol       Date:  2007-11-01       Impact factor: 3.064

4.  On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.

Authors:  E Petru; D Schmähl
Journal:  Klin Wochenschr       Date:  1987-10-15

Review 5.  Could aminoglutethimide replace adrenalectomy?

Authors:  A L Harris
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 6.  Gynecologic effects of tamoxifen: case reports and review of the literature.

Authors:  R M Caputo; L J Copeland
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 7.  First generation aromatase inhibitors--aminoglutethimide and testololactone.

Authors:  G Cocconi
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

Review 9.  Selection of optimal adjuvant endocrine therapy for early-stage breast cancer.

Authors:  Ahmad Al-Hajj; Ruth O'Regan
Journal:  Curr Treat Options Oncol       Date:  2006-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.